Abiopharma

New Form 8-K - Flora Growth Corp. Filed: 2025-08-27 AccNo: 0001062993-25-015011 Size: 228 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of …

New Form 3 - STEPAN CO Filed: 2025-08-27 AccNo: 0001127602-25-021002 Size: 9 KB

New Form 144 - GeneDx Holdings Corp. Filed: 2025-08-27 AccNo: 0002007317-25-000983 Size: 5 KB

Karnawat Sunil Ratilal 🟢 acquired 300.0K shares (1 derivative) of Rezolute, Inc. (RZLT) at $6.55 ($1.8M) Transaction Date: Aug 18, 2025 | Filing ID: 000934

New Form 8-K - Autonomix Medical, Inc. Filed: 2025-08-27 AccNo: 0001437749-25-027890 Size: 199 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Moreadith Randall 🟡 adjusted position in 47.7K shares (2 derivative) of Serina Therapeutics, Inc. (SER) at $7.01 Transaction Date: Aug 25, 2025 | Filing ID: 000005

New Form 144 - Phreesia, Inc. Filed: 2025-08-27 AccNo: 0001959173-25-005585 Size: 5 KB

Hemrajani Rekha 🔴 sold 10.7K shares of MAXCYTE, INC. (MXCT) at $2.09 Transaction Date: Jun 25, 2025 | Filing ID: 003155

New Form 3 - Rezolute, Inc. Filed: 2025-08-27 AccNo: 0000912282-25-000932 Size: 5 KB

New Form 144 - Medpace Holdings, Inc. Filed: 2025-08-27 AccNo: 0001969223-25-000675 Size: 5 KB

Travere Therapeutics Announces U.S. FDA Approves REMS Modification for FILSPARI® (sparsentan) in IgA Nephropathy

New Form 8-K - PHIBRO ANIMAL HEALTH CORP Filed: 2025-08-27 AccNo: 0001558370-25-011778 Size: 923 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Kooij Louise Frederika 🔴 sold 8.3K shares of NewAmsterdam Pharma Co N.V. (NAMS) at $24.86 Transaction Date: Aug 25, 2025 | Filing ID: 111738

New Form 424B3 - Phio Pharmaceuticals Corp. Filed: 2025-08-27 AccNo: 0001683168-25-006496 Size: 131 KB

Tilray Brands Successfully Regains Compliance withNasdaq’s Minimum Bid Price Requirement